Dr. Samaras is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Desk R35
Cleveland, OH 44195Phone+1 216-444-0293Fax+1 216-636-1937
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2006 - 2009
- UPMC Medical Education/MercyResidency, Internal Medicine, 2000 - 2003
- University of New England College of Osteopathic MedicineClass of 2000
Certifications & Licensure
- OH State License 2006 - 2026
- WV State License 2009 - 2011
- MI State License 2003 - 2006
- PA State License 2001 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014.Nizar J Bahlis, Christy Samaras, Donna Reece, Michael Sebag, Jeffrey Matous
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01 - 2 citationsOutcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy.Danai Dima, Michael Hughes, Mark Orland, Fauzia Ullah, Utkarsh Goel
Amyloid. 2024-09-01 - Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.Danai Dima, Utkarsh Goel, Aishwarya Sannareddy, Nnaemeka Ibeh, Fauzia Ullah
Hematological Oncology. 2024-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: